BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3995168)

  • 1. Heterogeneity of non-Hodgkin's lymphoma probed by nucleic acid cytometry.
    Srigley J; Barlogie B; Butler JJ; Osborne B; Blick M; Johnston D; Kantarjian H; Reuben J; Batsakis J; Freireich EJ
    Blood; 1985 May; 65(5):1090-6. PubMed ID: 3995168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA content of T-cell lymphomas. A flow-cytometric analysis.
    Egerter DA; Said JW; Epling S; Lee S
    Am J Pathol; 1988 Feb; 130(2):326-34. PubMed ID: 3257649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic importance of DNA flow cytometry in non-Hodgkin's lymphomas.
    Macartney JC; Camplejohn RS; Alder J; Stone MG; Powell G
    J Clin Pathol; 1986 May; 39(5):542-6. PubMed ID: 3722408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy, proliferative activities, and immunophenotype of malignant lymphoma: application of flow cytometry.
    Horii A; Yoshida J; Hattori K; Honjo Y; Mitani K; Takashima S; Sakai M; Okamoto S; Kubo T
    Head Neck; 1998 Aug; 20(5):392-8. PubMed ID: 9663666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of DNA flow cytometry from fresh and paraffin embedded samples of non-Hodgkin's lymphoma.
    Camplejohn RS; Macartney JC
    J Clin Pathol; 1985 Oct; 38(10):1096-9. PubMed ID: 4056064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of DNA flow cytometry in non-Hodgkin's lymphoma.
    Wu HM
    J Tongji Med Univ; 1992; 12(2):65-70. PubMed ID: 1433420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.
    Cowan RA; Harris M; Jones M; Crowther D
    Br J Cancer; 1989 Dec; 60(6):904-10. PubMed ID: 2605100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification.
    Christensson B; Tribukait B; Linder IL; Ullman B; Biberfeld P
    Cancer; 1986 Sep; 58(6):1295-304. PubMed ID: 3742454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study.
    Joensuu H; Klemi PJ; Jalkanen S
    Cancer; 1990 Jun; 65(11):2564-71. PubMed ID: 2337874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA content and kinetic characteristics of non-Hodgkin's lymphoma: determined by flow cytometry and autoradiography.
    Costa A; Mazzini G; Del Bino G; Silvestrini R
    Cytometry; 1981 Nov; 2(3):185-8. PubMed ID: 7297353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA content analysis of fine needle aspirates obtained from lymphatic tissue.
    Alanen KA; Joensuu H; Klemi PJ
    Anal Quant Cytol Histol; 1993 Aug; 15(4):259-64. PubMed ID: 8397647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleic acid flow cytometry in large cell lymphoma.
    McLaughlin P; Osborne BM; Johnston D; Jennings P; Butler JJ; Cabanillas F; Barlogie B
    Cancer Res; 1988 Nov; 48(22):6614-9. PubMed ID: 3180071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomas.
    Winter JN; Andersen J; Variakojis D; Gordon LI; Fisher RI; Oken MM; Neiman RS; Jiang S; Bauer KD
    Blood; 1996 Nov; 88(10):3919-25. PubMed ID: 8916958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy patterns and cytokinetics of non-Hodgkin's lymphoma.
    Juneja SK; Cooper IA; Hodgson GS; Wolf MM; Ding JC; Ironside PN; Thomas RJ; Parkin JD
    J Clin Pathol; 1986 Sep; 39(9):987-92. PubMed ID: 3760241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA aneuploidy and cell proliferation in relation to histology and prognosis in patients with Hodgkin's disease.
    Erdkamp FL; Breed WP; Schouten HC; Janssen WC; Hoffmann JJ; Wijnen JT; Blijham GH
    Ann Oncol; 1993 Jan; 4(1):75-80. PubMed ID: 8435368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of DNA-analysis by flow cytometry in non-Hodgkin's lymphoma.
    Roos G; Dige U; Lenner P; Lindh J; Johansson H
    Hematol Oncol; 1985; 3(4):233-42. PubMed ID: 4085977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies, and immune deficiency.
    McDunn SH; Winter JN; Variakojis D; Rademaker AW; Von Roenn JH; Tallman MS; Gordon LI; Bauer KD
    J Clin Oncol; 1991 Aug; 9(8):1334-40. PubMed ID: 1677032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
    Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR
    Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia.
    Diamond LW; Nathwani BN; Rappaport H
    Cancer; 1982 Sep; 50(6):1122-35. PubMed ID: 7104953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.